Pear Therapeutics

Tami Smith


Tami is a Medical Affairs professional with extensive experience launching game-changing therapeutics. Before joining Pear, Tami led the medical team for SSI Strategy, a boutique biopharma consulting firm that specializes in early-stage, innovative companies with industry-leading technologies. Tami also led Medical Affairs at Spark Therapeutics, building the organization from the ground up to launch the first gene therapy for a genetic disorder in the U.S. She was previously Senior Vice President of Global Medical Affairs for Shire Pharmaceuticals, and before that, held increasing levels of responsibility within Medical Affairs at Forest Laboratories and Allergan. She has also been an investment banking analyst with Bankers Trust Company.

Tami received her MD from Columbia University College of Physicians and Surgeons, and her bachelor’s from Cornell University.